WebManagement. Kevin Booth - CEO. Mr. Booth joined Synergy Biomedical as in June of 2015 as Vice President of Sales. Mr. Booth most recently was appointed CEO in July of … Web29 sep. 2011 · The company's technology represents an innovative approach to advancing bone graft processes, and improving bone healing and patient outcomes, enabling orthopedic surgeons with optimized bioactive particles for medical surgeries. Contact Information Website www.synergybiomedical.com Ownership Status Privately Held …
Synergy Biomedical Announces Publication of Core Scientific …
Web26 jan. 2024 · Synergy Biomedical, LLC, ... of Synergy Biomedical that identified bioactive glass spheres as an optimal particle for bone regeneration," stated Kevin Booth, CEO of Synergy Biomedical. WebWAYNE, Pa.–(BUSINESS WIRE)–Synergy Biomedical, LLC, a developer of innovative biomaterial products, today announced the launching of BIOSPHERE® FLEX SP EXTREMITIES, Synthetic Bioactive Bone Graft. Using Synergy’s proprietary BIOSPHERE® Technology, BIOSPHERE® FLEX SP Extremities is a sheet putty composed of … linda altherr oberwil
Synergy Biomedical Company Profile: Valuation & Investors
WebView the profiles of professionals named "Kevin Booth" on LinkedIn. There are 300+ professionals named "Kevin Booth", who use LinkedIn to exchange information, ideas, … WebView Kevin Booth's email address: [email protected] & phone: +1-xxx-xxx-7275's profile as Chief Executive Officer at Synergy Biomedical, located in Greater Philadelphia. Find contacts: direct phone number, email address, work experience. Web1 mrt. 2024 · WAYNE, Pa., March 01, 2024--Synergy Biomedical Launches BIOSPHERE® MIS II, Next Generation Minimally Invasive Bone Graft Delivery System. linda allston shaw